<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区

          News >World

          Women can't keep breast implants for life: FDA

          2011-06-23 15:15

          Women can't keep breast implants for life: FDA
          A surgeon holds a breast implant for a patient at his clinic in Caracas, November 5, 2009. [Photo/Agencies]

          Women who get silicone breast implants are likely to need additional surgery within 10 years to address complications such as rupturing of the device, US health regulators said on Wednesday.

          The Food and Drug Administration will work to revise safety labels for silicone breast implants after reviewing data from several long-term studies, which also showed that the products had a small link to a rare form of cancer.

          The agency said the studies overall confirmed its decision that implants can be used safely, but noted the conclusions could be limited because some women dropped out.

          "The key point is that breast implants are not lifetime devices," said Jeff Shuren, director of the FDA's Center for Devices and Radiological Health. "The longer you have the implant, the more likely you are to have complications."

          There were almost 400,000 breast enlargement or reconstruction procedures in the United States in 2010, according to the American Society of Plastic Surgeons. That includes silicone and saline implants.

          Up to 70 percent of all women who received surgery due to disease or trauma, and up to 40 percent of those getting an enlargement procedure using silicone, needed another operation within 10 years, post-approval studies showed.

          The FDA approved silicone gel-filled breast implants sold by Allergan and Johnson & Johnson's Mentor unit in 2006. It had banned silicone implants for most US women in 1992 after some complained that the devices leaked and made them chronically ill.

          As a condition of taking the devices to market, both companies were required to conduct post-approval studies of 40,000 women for 10 years, as well as extend smaller pre-approval studies. The FDA considered the companies' results, as well as reports of negative events and scientific literature.

          Localized Complications

          Based on the data, the FDA said most common complications were localized, such as the hardening of the breast area around the implant, rupture or deflation of it, and the need for additional surgeries.

          Other local complications include implant wrinkling, asymmetry, scarring, pain, and infection at the incision site.

          The report also found a small correlation between implants and anaplastic large-cell lymphoma, a form of cancer that affects about 3,000 Americans a year.

          From 1997 to 2010, there were about 60 cases of ALCL reported for women worldwide out of about 5 million to 10 million women who had breast implants, Shuren said.

          "If there's a true association between that cancer and implants, it's very, very rare," he said.

          The FDA said most long-term studies confirmed initial results, and that most risks of implants were well known.

          "Most women reported high levels of satisfaction with their body image and the shape, feel and size of their implants," the FDA report said, adding that they should monitor their breasts for the rest of their lives.

          The agency also cautioned that post-approval study data could be limited because of the low response rates.

          In the large 10-year studies of 80,000 women, Allergan has collected preliminary two-year data for 60 percent of participants, while Mentor has collected three-year data for only 21 percent.

          Diane Zuckerman, president of the advocacy group National Research Center for Women & Families, said the high dropout rates meant the study was not accurate.

          "So many of the women dropped out before the research was completed that it is impossible to say what percentage of women need additional surgery or have health problems five or 10 years after getting breast implants," she said.

          "This raises questions about FDA's reliance on studies required after a product is approved," she added.

          Allergan shares were down 0.9 percent at $82.04 on the New York Stock Exchange, while Johnson & Johnson dipped 0.2 percent to $66.36.

          Related News:

          主站蜘蛛池模板: 久久久久无码国产精品不卡| 国产欧美综合在线观看第十页 | 国内精品国产成人国产三级 | 永久免费无码国产| 在线中文字幕国产精品| 综合色久七七综合尤物| 狠狠躁天天躁中文字幕无码| 亚洲综合无码明星蕉在线视频| 伊人久久大香线蕉av一区| 国产a在视频线精品视频下载 | 最近高清中文在线字幕在线观看| 野花日本hd免费高清版8| 亚洲愉拍自拍欧美精品| 国产一精品一av一免费| 亚洲精品一区二区妖精| 5555国产在线观看| 免费a级毛片18以上观看精品| 久久AV中文综合一区二区| 人妻中文字幕亚洲精品| 亚洲一区精品一区在线观看| 亚洲国产高清第一第二区| 国产精品99一区二区三区| 国产999久久高清免费观看| 日本一本正道综合久久dvd| 成人亚洲精品久久久久| 中国女人内谢69xxxx| 99久久亚洲综合精品成人| 五月天中文字幕mv在线| 一区二区不卡99精品日韩| 99热精国产这里只有精品| 国产精品免费中文字幕| 国产在线观看一区精品| 天堂www在线中文| 无码日韩精品一区二区三区免费| 毛片无遮挡高清免费| 亚洲av噜噜一区二区| 亚洲中文一区二区av| 免费无码一区无码东京热| 精品中文人妻在线不卡| 精品夜恋影院亚洲欧洲| 日本无人区码卡二卡三卡|